Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Joseph C. Cappelleri & Paul R. Cislo. (2023) Special Issue PRO-Analysis of Clinically Meaningful Change on Patient-Reported Outcomes: Renewed Insights About Covariate Adjustment. Journal of Biopharmaceutical Statistics 0:0, pages 1-14.
Read now
Read now
Parker J. Funk, Patrick O. Perche, Rohan Singh, Katherine A. Kelly & Steven R. Feldman. (2022) Comparing available JAK inhibitors for treating patients with psoriasis. Expert Review of Clinical Immunology 18:3, pages 281-294.
Read now
Read now
Abraham M. Korman, Dane Hill, Ali Alikhan & Steven R. Feldman. (2016) Oral tofacitinib for the treatment of adults with moderate to severe chronic plaque psoriasis. Expert Review of Clinical Pharmacology 9:4, pages 525-539.
Read now
Read now
Carolyn Stull, Michael J. Lavery & Gil Yosipovitch. (2016) Advances in therapeutic strategies for the treatment of pruritus. Expert Opinion on Pharmacotherapy 17:5, pages 671-687.
Read now
Read now
Articles from other publishers (26)
Emilie Sbidian, Anna Chaimani, Robin Guelimi, Ignacio Garcia-Doval, Camille Hua, Carolyn Hughes, Luigi Naldi, Maria Kinberger, Sivem Afach & Laurence Le Cleach. (2023) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2023:7.
Crossref
Crossref
Marie Mc Carthy, Kate Burrows, Pip Griffiths, Peter M. Black, Charmaine Demanuele, Niklas Karlsson, Joan Buenconsejo, Nikunj Patel, Wen-Hung Chen & Joseph C. Cappelleri. (2023) From Meaningful Outcomes to Meaningful Change Thresholds: A Path to Progress for Establishing Digital Endpoints. Therapeutic Innovation & Regulatory Science 57:4, pages 629-645.
Crossref
Crossref
Andrew G. Bushmakin & Joseph C. Cappelleri. 2022. A Practical Approach to Quantitative Validation of Patient‐Reported Outcomes. A Practical Approach to Quantitative Validation of Patient‐Reported Outcomes
295
334
.
Reinhart Speeckaert, Arno Belpaire, Sandrine Herbelet, Jo Lambert & Nanja van Geel. (2022) Credibility and Generalization of the Minimally Important Difference Concept in Dermatology. JAMA Dermatology 158:11, pages 1304.
Crossref
Crossref
Samantha Sarabia, Brandan Ranjith, Sahil Koppikar & Don Thiwanka Wijeratne. (2022) Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis. BMC Rheumatology 6:1.
Crossref
Crossref
Mariabeth Silkey, Gonzalo Durán-Pacheco, Michelle Johnson, Chuang Liu, Susanne Clinch, Kiely Law & Georg Loss. (2022) The Autism Impact Measure (AIM): Meaningful Change Thresholds and Core Symptom Changes Over One Year from an Online Survey in the U.S.. Journal of Autism and Developmental Disorders.
Crossref
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2022) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2022:8.
Crossref
Crossref
Margaret K. Vernon, Laura L. Swett, Rebecca M. Speck, Catherine Munera, Robert H. Spencer, Warren Wen & Frédérique Menzaghi. (2021) Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritus. Journal of Patient-Reported Outcomes 5:1.
Crossref
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2021) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2021:12.
Crossref
Crossref
Margaret Vernon, Sonja Ständer, Catherine Munera, Robert H. Spencer & Frédérique Menzaghi. (2021) Clinically meaningful change in itch intensity scores: An evaluation in patients with chronic kidney disease–associated pruritus. Journal of the American Academy of Dermatology 84:4, pages 1132-1134.
Crossref
Crossref
Craig A. Elmets, Neil J. Korman, Elizabeth Farley Prater, Emily B. Wong, Reena N. Rupani, Dario Kivelevitch, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn M.R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Michael Siegel, Benjamin Stoff, Bruce Strober, Jashin J. Wu, Vidhya Hariharan & Alan Menter. (2021) Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. Journal of the American Academy of Dermatology 84:2, pages 432-470.
Crossref
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2020) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
B. Elewski, A.F. Alexis, M. Lebwohl, L. Stein Gold, D. Pariser, J. Del Rosso & G. Yosipovitch. (2019) Itch: an under‐recognized problem in psoriasis. Journal of the European Academy of Dermatology and Venereology 33:8, pages 1465-1476.
Crossref
Crossref
Nayoung Lee & Gil Yosipovitch. 2019. Alopecia. Alopecia
219
228
.
Matthew W. McEwen, Elizabeth M. Fite, Gil Yosipovitch & Tejesh Patel. (2018) Drugs on the Horizon for Chronic Pruritus. Dermatologic Clinics 36:3, pages 335-344.
Crossref
Crossref
Joseph C. Cappelleri & Andrew G. Bushmakin. 2018. Biopharmaceutical Applied Statistics Symposium. Biopharmaceutical Applied Statistics Symposium
69
89
.
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Giao Do, Camille Hua, Canelle Mazaud, Catherine Droitcourt, Carolyn Hughes, John R Ingram, Luigi Naldi, Olivier Chosidow & Laurence Le Cleach. (2017) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Rony Shreberk-Hassidim, Yuval Ramot & Abraham Zlotogorski. (2017) Janus kinase inhibitors in dermatology: A systematic review. Journal of the American Academy of Dermatology 76:4, pages 745-753.e19.
Crossref
Crossref
C.E.M. Griffiths, R. Vender, H. Sofen, L. Kircik, H. Tan, S.T. Rottinghaus, M. Bachinsky, L. Mallbris & C. Mamolo. (2017) Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis. Journal of the European Academy of Dermatology and Venereology 31:2, pages 323-332.
Crossref
Crossref
Kim A. Papp, Robert Bissonnette, Melinda Gooderham, Steven R. Feldman, Lars Iversen, Jennifer Soung, Zoe Draelos, Carla Mamolo, Vivek Purohit, Cunshan Wang & William C. Ports. (2016) Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial. BMC Dermatology 16:1.
Crossref
Crossref
Steven R. Feldman, Diamant Thaçi, Melinda Gooderham, Matthias Augustin, Claudia de la Cruz, Lotus Mallbris, Marjorie Buonanno, Svitlana Tatulych, Mandeep Kaur, Shuping Lan, Hernan Valdez & Carla Mamolo. (2016) Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology 75:6, pages 1162-1170.e3.
Crossref
Crossref
Carolyn Stull, Shoshana Grossman & Gil Yosipovitch. (2016) Current and Emerging Therapies for Itch Management in Psoriasis. American Journal of Clinical Dermatology 17:6, pages 617-624.
Crossref
Crossref
F. Valenzuela, C. Paul, L. Mallbris, H. Tan, J. Papacharalambous, H. Valdez & C. Mamolo. (2016) Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient‐reported outcomes from a Phase 3 study. Journal of the European Academy of Dermatology and Venereology 30:10, pages 1753-1759.
Crossref
Crossref
Cheryl D. Coon & Joseph C. Cappelleri. (2016) Interpreting Change in Scores on Patient-Reported Outcome Instruments. Therapeutic Innovation & Regulatory Science 50:1, pages 22-29.
Crossref
Crossref
Carolyn Stull, Michael Joseph Lavery & Gil Yosipovitch. 2016. Pruritus. Pruritus
397
406
.
Macy M. S. Wu, Gordon S. K. Yau, Jacky W. Y. Lee, Amy L. Wong, Victor T. Y. Tam & Can Y. F. Yuen. (2014) Retrospective Review on the Use of Topical Cyclosporin A 0.05% for Paediatric Allergic Conjunctivitis in Hong Kong Chinese. The Scientific World Journal 2014, pages 1-5.
Crossref
Crossref